NRT Smoking Cessation Aids in the US

NRT Smoking Cessation Aids in the US

  • November 2017 •
  • 21 pages •
  • Report ID: 149238
NRT smoking cessation aids’ consumer base continued to shrink in 2017, causing retail current value growth to slow slightly. Adult smoking prevalence in the US has continued to fall, standing at 15% in 2016, down from 18% in 2012. Tobacco products are highly regulated in the US, with smoking restrictions continuing to be introduced in areas such as public housing, cars carrying children, university campuses and outdoor public spaces like parks and beaches. Smoking bans are also being expanded to...

Euromonitor International’s NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage:
NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=UnitedStates Industry=OTC ParentIndustry=LifeSciences Date=201711 Topic=Demand Publisher=EuromonitorInternational Price=1000